Antiseptics & Disinfectants: Worldwide Market Analysis & Forecast, 2019-2026 – A $28 Billion Opportunity, Growing at a CAGR of 6.7%

NEXT STORY
Oncology Venture publishes the Annual Report for 2018
PREV STORY
Novo Nordisk files oral semaglutide for US regulatory approval of glycaemic control, as well as for CV risk reduction for oral semaglutide and Ozempic®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Inovalon Reports Second Quarter 2021 Results

author_avatar
NASDAQ Market News

Lyophilized Injectables Market to 2020 – Analyze Therapeutic Demand Drivers and Evaluate Lyophilized Drugs in Eleven Therapeutic Areas

Dublin, Jan. 26, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/n8vbnd/lyophilized) has announced the ...

author_avatar
NASDAQ Market News

XBiotech to Provide First Quarter 2016 Business Update on May 18

AUSTIN, Texas, May 11, 2016 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT), developer of True ...

author_avatar
NASDAQ Market News